相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuropsychological Outcomes of Older Breast Cancer Survivors: Cognitive Features Ten or More Years After Chemotherapy
Torricia H. Yamada et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
Aging, Cellular Senescence, and Cancer
Judith Campisi
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study
Brenna C. McDonald et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Patricia A. Ganz et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors
Shelli Kesler et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer
K. L. Pomykala et al.
BRAIN IMAGING AND BEHAVIOR (2013)
Cognitive function and breast cancer: promise and potential insights from functional brain imaging
Patricia A. Reuter-Lorenz et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Null Association between Tamoxifen Use and Dementia in Danish Breast Cancer Patients
Anne Gulbech Ording et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Cognitive effects of chemotherapy in breast cancer patients: a dose-response study
Barbara Collins et al.
PSYCHO-ONCOLOGY (2013)
Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?
Jeanne S. Mandelblatt et al.
SEMINARS IN ONCOLOGY (2013)
Brief self-report measure of work-related cognitive limitations in breast cancer survivors
Alicia Ottati et al.
JOURNAL OF CANCER SURVIVORSHIP (2013)
Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease Results From the Framingham Heart Study
Thomas M. van Himbergen et al.
ARCHIVES OF NEUROLOGY (2012)
Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study
Carole Scherling et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2012)
Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
Vincent Koppelmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy
Heather S. L. Jim et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
Chemotherapy Was Not Associated With Cognitive Decline in Older Adults With Breast and Colorectal Cancer Findings From a Prospective Cohort Study
Victoria A. Shaffer et al.
MEDICAL CARE (2012)
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study
C. M. T. Schilder et al.
PSYCHO-ONCOLOGY (2012)
Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis
Mostafa Saadat
CANCER RESEARCH AND TREATMENT (2012)
Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study
Jane A. Driver et al.
BRITISH MEDICAL JOURNAL (2012)
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
Kelly-Anne Phillips et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Catechol-O-Methyltransferase Genotype Modulates Cancer Treatment-Related Cognitive Deficits in Breast Cancer Survivors
Brent J. Small et al.
CANCER (2011)
The Center for Epidemiological Studies Depression Scale (CES-D) is an adequate screening instrument for depressive and anxiety disorders in a very old population living in residential homes
Els Dozeman et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
Jeffrey S. Wefel et al.
LANCET ONCOLOGY (2011)
Is the Apolipoprotein E Genotype a Biomarker for Mild Cognitive Impairment? Findings From a Nationally Representative Study
Charles J. Brainerd et al.
NEUROPSYCHOLOGY (2011)
The Attentional Function Index-a self-report cognitive measure
Bernadine Cimprich et al.
PSYCHO-ONCOLOGY (2011)
A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients
Catherine E. Jansen et al.
SUPPORTIVE CARE IN CANCER (2011)
Visceral adiposity, insulin resistance and cancer risk
Claire L. Donohoe et al.
DIABETOLOGY & METABOLIC SYNDROME (2011)
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study
Brenna C. McDonald et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer
Jeffrey S. Wefel et al.
CANCER (2010)
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors
C. M. T. Schilder et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
The Challenge of Multiple Comorbidity for the US Health Care System
Anand K. Parekh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Prechemotherapy alterations in brain function in women with breast cancer
Bernadine Cimprich et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2010)
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Impact of Age, Sex, and Comorbidity on Cancer Therapy and Disease Progression
Sumanta Kumar Pal et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Patterns of Comorbid Inflammatory Diseases in Frail Older Women: The Women's Health and Aging Studies I and II
Sandy S. Chang et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2010)
Neural mechanisms of ageing and cognitive decline
Nicholas A. Bishop et al.
NATURE (2010)
ALTERATIONS IN BRAIN ANTIOXIDANT ENZYMES AND REDOX PROTEOMIC IDENTIFICATION OF OXIDIZED BRAIN PROTEINS INDUCED BY THE ANTI-CANCER DRUG ADRIAMYCIN: IMPLICATIONS FOR OXIDATIVE STRESS-MEDIATED CHEMOBRAIN
G. Joshi et al.
NEUROSCIENCE (2010)
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy
Christina M. Schilder et al.
PSYCHO-ONCOLOGY (2010)
The Alzheimer's Disease Centers' Uniform Data Set (UDS) The Neuropsychologic Test Battery
Sandra Weintraub et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy
Mimi Mehlsen et al.
PSYCHO-ONCOLOGY (2009)
Short-Term Effects of Treatment-Induced Hormonal Changes on Cognitive Function in Breast Cancer Patients Results of a Multicenter, Prospective, Longitudinal Study
Kerstin Hermelink et al.
CANCER (2008)
Neurocognitive Changes in Cancer Survivors
Denise D. Correa et al.
CANCER JOURNAL (2008)
Cognitive function in breast cancer patients prior to adjuvant treatment
Tim A. Ahles et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?
Arti Hurria et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Comprehensive geriatric assessment for older patients with cancer
Martine Extermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Evaluation of the Functional Assessment of Cancer Therapy Cognitive Scale with hematopoetic stem cell transplant patients
Sheri R. Jacobs et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective
Arti Hurria et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Short-term monitoring of cognitive functions before and during the first course of treatment
B Eberhardt et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer
A Stewart et al.
CLINICAL NEUROPSYCHOLOGIST (2006)
The (mis)classification of chemo-fog - methodological inconsistencies in the investigation of cognitive impairment after chemotherapy
V Shilling et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study
Arti Hurria et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Healthy and pathological processes in adult development: new evidence from neuroimaging of the aging brain
T Hedden et al.
CURRENT OPINION IN NEUROLOGY (2005)
Explaining differences in attitude toward adjuvant chemotherapy between experienced and inexperienced breast cancer patients
SJT Jansen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Frontal-hippocampal double dissociation between normal aging and Alzheimer's disease
D Head et al.
CEREBRAL CORTEX (2005)
The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observational longitudinal study
V Shilling et al.
BREAST (2005)
Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer
B Cimprich et al.
PSYCHO-ONCOLOGY (2005)
Cancer in older persons: An international issue in an aging world
R Yancik et al.
SEMINARS IN ONCOLOGY (2004)
Vitamin B12 and folate depletion - Clinical evidence in a neurological population
R Moretti et al.
NEUROLOGIST (2004)
Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer
J Blasiak et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2004)
Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature
C Anderson-Hanley et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2003)
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy
TA Ahles et al.
PSYCHO-ONCOLOGY (2003)
International physical activity questionnaire:: 12-country reliability and validity
CL Craig et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)
Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients
LS Rasmussen et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2003)
Cytokines and cognition - The case for a head-to-toe inflammatory paradigm
CJ Wilson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)
Postoperative cognitive dysfunction in middle-aged patients
T Johnson et al.
ANESTHESIOLOGY (2002)
APOE-epsilon 4 and APOE-491A polymorphisms in individuals with subjective memory loss
SM Laws et al.
MOLECULAR PSYCHIATRY (2002)
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation
CP Schröder et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
